Health  Vol.6 No.4 , February 2014
Relationship between expression of Aurka and clinicopathological characteristics in gastric cancer patients
Abstract: The aim of the study was to clarify the role of Aurka in the process of formation and development of gastric cancer. The expression of Aurka in gastric cancer and corresponding non-cancerous gastric tissues of 52 gastric cancer patients was assessed with the real-time fluorescence quantitative polymerase chain reaction (RT-PCR) and immunohistochemistry. We also analyzed the relationship between the expression level and clinicopathological characteristics. Aurka gene and protein expression in gastric cancer tissues in both cases were significantly higher than in corresponding non-cancerous gastric tissues (both P < 0.01), but no significant relationship was found with clinicopathological parameters including tumor location, depth of invasion, differentiation, lymph node metastasis, stage, gender, age and carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9) level in peripheral blood preoperation of patients (P > 0.05, respectively). Furthermore, Aurka gene expression was markedly higher in gastric cancer tissues of Helicobacter pylori (HP)-positive patients than negative ones (P < 0.05). The result of the study showed that Aurka might play a significant role in the process of formation and development of gastric cancer as an oncogene. Its effect might be strengthened by HP infection.
Cite this paper: Xu, X. , Xiao, J. , Wei, S. , Xie, X. , Huang, Y. , Tian, X. and Wang, C. (2014) Relationship between expression of Aurka and clinicopathological characteristics in gastric cancer patients. Health, 6, 243-249. doi: 10.4236/health.2014.64036.

[1]   Ferlay, J., Shin, H.R., Bray, F., et al. (2008) GLOBOCAN vl.2, cancer incidence and mortality worldwide: IARC Cancer Base No.10 [DB/OL].

[2]   Marumoto, T., Zhang, D. and Saya, H. (2005) Aurora-A: A guardian of poles. Nature Reviews Cancer, 5, 42-50.

[3]   Zhou, H., Kuang, J., Zhong, L., et al. (1998) Tumor amplified kinase STK15P BTAK induces centrosome amplification aneuploidy and transformation. Nature Genetics, 20, 189-193.

[4]   Gritsko, T.M., Coppola, D., Paciga, J.E., et al. (2003) Activation and over expression of centrosome kinase BTAKP/Aurora-A in human ovarian cancer. Clinical Cancer Research, 9, 1420-1426.

[5]   Tanaka, E., Hashimoto, Y., Ito, T., et al. (2005) The clinical significance of Aurora-A PSTK15/BTAK expression in human esophageal squamous cell carcinoma. Clinical Cancer Research, 11, 1827-1834.

[6]   Sakakura, C., Hagiwara, A., Yasuoka, R., et al. (2001) Tumour amplified kinase BTAK is amplified and over expressed in gastric cancers with possible involvement in aneuploid formation. British Journal of Cancer, 84, 824-831.

[7]   Bischoff, J.R., Anderson, L., Zhu, Y., et al. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO Journal, 17, 3052-3065.

[8]   Dar, A.A., Zaika, A., Piazuelo, M.B., et al. (2008) Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer, 11, 1688-1698.

[9]   Sugimoto, K., Urano, T., Zushi, H., et al. (2002) Molecular dynamics of aurora-A kinase in living mitotic cells simultaneously visualized with histone H3 and nuclear membrane protein importin α. Cell Structure and Function, 27, 457-467.

[10]   Roghi, C., Giet, R., Uzbekov, R., et al. (1998) The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. Cell Science, 111, 557-572.

[11]   Warner, S.L., Bearss, D.J., Han, H., et al. (2003) Targeting aurora-2 kinase in cancer. Molecular Cancer Therapeutics, 2, 589-595.

[12]   Keen, N. and Taylor, S. (2004) Aurora-kinase inhibitors as anticancer agents. Nature Reviews, 4, 927-936.

[13]   Sen, S., Zhou, H. and White, R.A. (1997) A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene, 14, 2195-2200.

[14]   Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.

[15]   Vogelstein, B. and Kinzler, K.W. (2004) Cancer genes and the pathways they control. Nature Medicine, 10, 789-799.

[16]   Meraldi, P., Honda, R. and Nigg, E.A. (2002) Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells[J]. EMBO Journal, 21, 483-492.

[17]   Anand, S., Penrhyn-Lowe, S. and Venkitaraman, A.R. (2003) Aurora-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to taxol. Cancer Cell, 3, 51-62.

[18]   Rugge, M., Fassan, M., Zaninotto, G., et al. (2010) Aurora kinase A in Barrett’s carcinogenesis. Human Pathology, 41, 1380-1386.

[19]   Gisbert, J.P. (2011) Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer. Gastroenterology and Hepatology, 34, 15-26.

[20]   Zhang, Q.Y. and Qian, L. (2006) Abdominal surgery. People’s Health Publishing House, Bei Jing, 157-161.

[21]   Weck, M.N., Gao, L. and Brenner, H. (2009) Helicobacter pylori infection anchronic atrophic gastritis: Associations according to severity of disease. Epidemiology, 20, 569-574.

[22]   Ohata, H., Kitauchi, S., Yoshimura, N., et al. (2004) Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. International Journal of Cancer, 109, 138-143.

[23]   Zhang, Y.L., Xue, Y.W., Lan, X.W., et al. (2010) CA19-9, CEA tumor marker analysis of gastric cancer metastasis and prognosis value. Journal of Harbin Medical University, 44, 181-184.

[24]   Ucar, E., Semerci, E., Ustun, H., et al. (2008) Prognostic value of preoperative CEA,CA19-9,CA72-4,and AFP levels in gastric cancer. Advances in Therapy, 25, 1075-1084.